PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems

Vaccine

Volumn 17, Issue 22, 1999, Pages 2927-2938

  Delgado, A ^a   Lavelle, E C ^a   Hartshorne, M ^a   Davis, S S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

CMEC; Eudragit; Oral delivery; Ovalbumin; PLG microparticles; Vaccine

Indexed keywords

ANTIGEN; CARBOXYMETHYLCELLULOSE; EUDRAGIT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; OVALBUMIN; PEPSIN A; POLYGLACTIN; POLYVINYL ALCOHOL; RESOMER RG 103; TRYPSIN; UNCLASSIFIED DRUG; VACCINE;

ANTIBODY PRODUCTION; ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; ENTERIC COATED TABLET; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH JUICE; SURFACE PROPERTY; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTIC ACID; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; OVALBUMIN; POLYGLYCOLIC ACID; POLYMERS; SURFACE PROPERTIES; VACCINES;

EID: 0033575434     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00140-1     Document Type: Article

References (33)

1. Challacombe S.J., Rahman D., Jeffery H., Davis S.S., O'Hagan D.T. Enhanced secretory IgA and systemic IgG antibody responses after oral immmunization with biodegradable microparticles containing antigen. Immunology. 76:1992;164-168.
2. Cox D.S., Taubman M.A. Oral induction of the secretory immune response by soluble and particulate antigens. Int Archs Allergy Appl Immun. 75:1984;126-131.
3. Lavelle E.C., Jenkins P.G., Harris J.E. Oral immunisation of rainbow trout with antigen microencapsulated in poly (DL-lactide-co-glycolide) microparticles. Vaccine. 15:1997;1070-1078.
4. Aguado M.T., Lambert P.H. Controlled release vaccines-biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles. Immunobiology. 184:1992;113-125.
5. Coombes A.G.A., Lavelle E.C., Jenkins P.G., Davis S.S. Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. Vaccine. 14:1996;1429-1437.
6. Takahata H., Lavelle E.C., Coombes A.G.A., Davis S.S. The distribution of protein associated with poly (DL-lactide-co-glycolide) microparticles and its degradation in simulated body fluids. J Control Rel. 50:1998;237-246.
7. O'Hagan D.T. Microparticles as oral vaccines. O'Hagan D.T. Novel delivery systems for oral vaccines. 1994;175-205 CRC Press, Boca Raton.
8. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J Control Rel. 11:1990;205-214.
9. Lavelle E.C., Sharif S., Thomas N.W., Holland J., Davis S.S. The importance of gastrointestinal uptake of particles in the design of oral delivery systems. Adv Drug Deliv Rev. 18:1995;5-22.
10. Florence A.T. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm Res. 14:1997;259-266.
11. Michael J.G. The role of digestive enzymes in orally induced immune tolerance. Immunol Invest. 18:1989;1049-1054.
12. Challacombe S.J., Rahman D., O'Hagan D.T. Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles. Vaccine. 15:1997;169-175.
13. Klipstein F.A., Engert R.F., Sherman W.T. Peroral immunization with Escherichia coli heat-labile enterotoxin delivered by microspheres. Infect Immun. 39:1983;1000-1003.
14. Morishita I., Morishita M., Takayama K., Machida Y., Nagai T. Enteral insulin delivery by microspheres in 3 different formulations using Eudragit L100 and S100. Int J Pharm. 91:1993;29-37.
15. Maharaj I., Nairn J.G., Campbell J.B. Simple rapid method for the preparation of enteric-coated microspheres. J Pharm Sci. 73:1984;39-42.
16. Lin S.Y., Tzan Y.L., Lee C.J., Weng C.N. Preparation of enteric-coated microspheres of Mycoplasma hyopneumoniae vaccine with cellulose acetate phthalate: I. Formation condition and micromeritic properties. J Microencapsulation. 8:1991;317-325.
17. Guzmán M., Molpeceres J., García F., Aberturas M.R. Preparation, characterization and in vitro drug release of poly-ε-caprolactone and hydroxypropyl methylcellulose phthalate ketoprofen loaded microspheres. J Microencapsulation. 13:1996;25-39.
18. Jain S.L., Barone K.S., Flanagan M.P., Michael J.G. Activation patterns of murine B cells after oral administration of an encapsulated soluble antigen. Vaccine. 14:1996;42-48.
19. Wagner C.D., Davis L.E., Zeller M.V., Taylor J.A., Raymond R.M., Gale L.H. Surface and Interface Analysis. 3:1981;211-225.
20. US Pharmacopeia/National Formulary 23 rev; Ed: United States Pharmacopeial Convention, Inc 1995.
21. Laemmli U.K. Cleavage of the structural protein during the assembly of the head of bacteriophage T4. Nature. 227:1970;600-605.
22. Shard A.G., Volland C., Davies M.C., Kissel T. Information on the monomer sequence of poly (lactic acid) and random copolymers of lactic acid and glycolic acid by examination of static secondary ion mass spectrometry ion intensities. Macromolecules. 29:1996;748-754.
23. Shakesheff K.M., Evora C., Soriano I., Langer R. The adsorption of Poly(vinyl alcohol) to biodegradable microparticles studied by X-ray photoelectron spectroscopy (XPS). J Colloid and Interface Sci. 185:1997;538-547.
24. Rafati H., Lavelle E.C., Coombes A.G.A., Stolnik S., Holland J., Davis S.S. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants. Vaccine. 15:1997;1888-1897.
25. Manning M.C., Patel K., Borchardt R.T. Stability of protein pharmaceuticals. Pharm Res. 6:1989;903-918.
26. Lu W., Park T.G. Protein release from poly(lactic-co-glicolic acid) microspheres: protein stability problems. PDA J Pharm Sci & Tech. 49:1995;13-19.
27. Jani P.U., Florence A.T., McCarthy D.E. Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. Int J Pharm. 84:1992;245-252.
28. Jepson M.A., Simmons N.L., O'Hagan D.T., Hirst B.H. Comparison of poly (DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells. J Drug Targeting. 1:1993;245-249.
29. Carr K.E., Hazzard R.A., Reid S., Hodges G.M. The effect of size on uptake of orally administered latex microparticles in the small intestine and transport to mesenteric lymph nodes. Pharm Res. 13:1996;1205-1209.
30. Desai M.P., Labhasetwar V., Amidon G.L., Levy R.J. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res. 13:1996;1838-1845.
31. Jenkins P.G., Howard K.A., Blackhall N.W., Thomas N.W., Davis S.S., O'Hagan D.T. Microparticulate absorption from the rat intestine. J Control Rel. 29:1994;339-350.
32. O'Hagan D.T., McGee J.P., Holmgren J., Mowat McI A., Donachie A.M., Mills K.H.G., Gaisford W., Rahman D., Challacombe S.J. Biodegradable microparticles as oral vaccines. Vaccine. 11:1993;149-154.
33. Maloy K.J., Donachie A.M., O'Hagan D.T., Mowat McI A. Induction of mucosal and systemic immune responses by immunisation with ovalbumin entrapped in poly (lactide-co-glycolide) microparticles. Immunology. 81:1994;661-667.